Oregon Administrative Rules › Chapter 855 - BOARD OF PHARMACY › Division 41 - OPERATION OF PHARMACIES › Section 855-041-7050 - Definitions - Long Term Care Pharmacy

Current through Register Vol. 63, No. 7, July 1, 2024
As used in OAR 855-041-7000 through
				855-041-7080:
(1) "Long term care facility" means a
			 facility with permanent facilities that include inpatient beds, providing
			 medical services, including nursing services but excluding surgical procedures
			 except as may be permitted by the rules of the director, to provide treatment
			 for two or more unrelated patients. "Long Term Care facility" includes skilled
			 nursing facilities and intermediate care facilities but may not be construed to
			 include facilities licensed and operated pursuant to ORS
			 443.400 to
			 443.455.
(2) For the purposes of Schedule II
			 prescriptions in 21 CFR
			 1306.11 (04/01/2023),
			 21 CFR
			 1306.12 (04/01/2023),
			 21 CFR
			 1306.13 (04/01/2023),
			 21 CFR
			 1306.14 (04/01/2023), and
			 21 CFR
			 1306.15 (04/01/2023), the DEA definition of
			 "long term care facility" as defined in
			 21 CFR
			 1300.01 (04/01/2023) includes
			 "community-based care facilities."
(3) "Community Based Care Facility" means a
			 home, facility or supervised living environment licensed or certified or
			 otherwise recognized by an agency of the state of Oregon which provides 24-hour
			 care, supervision, and assistance with medication administration. These include
			 but are not limited to Adult Foster Homes, Residential Care Facilities (RCF),
			 Assisted Living Facilities (ALF), Intermediate Care Facilities for Individuals
			 with Intellectual Disabilities and Inpatient Hospice.
(4) "Pharmaceutical Care" means the
			 responsible provision of any or all of the following services by the
			 pharmacist:
(a) Develop and maintain policies
			 and procedures for pharmaceutical services;
(b) Provide direction and oversight regarding
			 all aspects of the acquisition, disposition, handling, storage, and
			 administration of drugs including but not limited to the following:
(A) Receipt and interpretation of physician's
			 orders;
(B) Ordering and receiving
			 of medications;
(C) Handling of
			 emergency drugs and supplies;
(D)
			 Labeling of all drugs;
(E)
			 Selection of drug delivery systems;
(F) Development of systems to provide timely
			 delivery of drugs and supplies;
(G)
			 Monitoring of drug storage conditions and expiration dates;
(H) Monitoring accuracy and efficiency of
			 medication administration and compliance with physician's orders;
(I) Establishing and monitoring of
			 appropriate record keeping;
(J)
			 Accountability of controlled substances;
(K) Return, release, and/or destruction of
			 discontinued or outdated drugs; and
(L) Compliance with state and federal laws
			 and regulations related to pharmaceutical services and medication
			 management.
(c) Provide
			 training and in-service education to facility staff;
(d) Perform drug regimen review for each
			 resident on a regularly scheduled basis for the purpose of promoting
			 therapeutic appropriateness and achieving the desired drug therapy outcomes by
			 identifying issues such as:
(A)
			 Over-utilization or underutilization;
(B) Therapeutic duplication;
(C) Drug-disease contraindications;
(D) Drug-drug interactions;
(E) Incorrect drug, drug dosage or duration
			 of drug treatment;
(F) Drug-allergy
			 interaction;
(G) Clinical
			 abuse/misuse;
(H) Untreated
			 indication;
(I) Monitoring and
			 assessing of drug therapy outcomes;
(e) Communicate effectively with residents'
			 physicians and facility staff; and
(f) Participate in resident care
			 planning.